Schonfeld Strategic Advisors LLC Novavax Inc Transaction History
Schonfeld Strategic Advisors LLC
- $14.6 Billion
- Q2 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Novavax Inc stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 22,901 shares of NVAX stock, worth $231,758. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,901Holding current value
$231,758% of portfolio
0.0%Shares
10 transactions
Others Institutions Holding NVAX
# of Institutions
281Shares Held
84.7MCall Options Held
5.43MPut Options Held
9M-
Vanguard Group Inc Valley Forge, PA14.1MShares$142 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$120 Million0.0% of portfolio
-
Shah Capital Management9.82MShares$99.3 Million40.63% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY6.32MShares$64 Million0.08% of portfolio
-
State Street Corp Boston, MA6.07MShares$61.4 Million0.0% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $792M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...